The manufacturer Accord will be out of stock of the anti-epileptic drug Phenytoin Sodium NRIM 100mg capsules until ‘early May’.
The Department of Health and Social Care issued a supply disruption alert today (10 January), which contains advice on how to manage patients affected by the shortage.
The Pharmaceutical Services Negotiating Committee noted that as phenytoin is a category 1 anti-epileptic drug, it is recommended that patients are kept of a specific manufacturer’s product.
The negotiator noted that an alternative phenytoin sodium 100mg capsules manufactured by Flynn Pharma is available but warned that ‘switching to an alternative formulation requires monitoring and may also require specialist support, advice or referral’.
Want news like this straight to your inbox?
Latest News
Covid booster jab plan released over ‘next few weeks’, says Hancock
Plans for the Covid booster jab programme this autumn will be released over the next...
Resurgence of flu expected alongside another winter wave of Covid, warns CMO
Pharmacy teams should expect a resurgence of flu cases alongside another winter wave of Covid,...
